BIOLASE Schedule Of Investor Conferences For September 2021

BIOLASE, Inc. (NASDAQ: BIOL) announced its schedule for investor conferences in September 2021.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

BIOLASE, Inc. (NASDAQ: BIOL) announced its schedule for investor conferences in September 2021. Key events include one-on-one meetings at the Colliers 2021 Institutional Conference on September 9 and a formal presentation at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, with the presentation available on September 13 at 7:00 am ET. The company's leadership, including CEO John Beaver and VP of Finance Jennifer Bright, will participate in virtual meetings with institutional investors. More details can be found on BIOLASE's investor relations website.

Positive

Scheduled participation in key investor conferences enhances visibility among institutional investors.
CEO and VP of Finance will be directly engaging with potential investors, which may foster investor relations.

Negative

None.

Argus Session date unavailable

+4.39% session move Open Argus

Details

News Market Reaction – BIOL

The recorded move for BIOL in the trading session of this news was +4.39%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

09/08/2021 - 04:05 PM EDT

FOOTHILL RANCH, Calif., Sept. 8, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021:

Colliers 2021 Institutional Conference
Thursday, September 9 (one-on-one meetings only)

H.C. Wainwright 23^rd Annual Global Investment Conference
Thursday, September 13-15^th (formal presentation available September 13^th at 7:00 am ET)

BIOLASE president and CEO John Beaver, and Vice President of Finance, Jennifer Bright will be hosting virtual one-on-one meetings with institutional investors at these conferences. For additional information or to schedule a virtual meeting with management, please contact your representative at the firms hosting the conferences, or BIOLASE's investor relations firm, EVC Group (contact info below).

To access a webcast of BIOLASE's presentation at the H.C. Wainwright conference, please visit the investor relations section of BIOLASE's website at www.biolase.com.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE^®, Waterlase^® and Waterlase iPlus^® are registered trademarks of BIOLASE, Inc.

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-schedule-of-investor-conferences-for-september-2021-301371708.html

SOURCE BIOLASE, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor conferences is BIOLASE attending in September 2021?

BIOLASE is attending the Colliers 2021 Institutional Conference on September 9 and the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15.

When will BIOLASE's formal presentation be available at the H.C. Wainwright conference?

The formal presentation will be available on September 13, 2021, at 7:00 am ET.

Who will represent BIOLASE at the September investor conferences?

BIOLASE's president and CEO John Beaver and Vice President of Finance Jennifer Bright will represent the company at the conferences.

How can I access BIOLASE's presentation at the investor conferences?

You can access the webcast of BIOLASE's presentation at the H.C. Wainwright conference by visiting the investor relations section of BIOLASE's website.

BIOLASE Schedule Of Investor Conferences For September 2021